¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"glomerular filtration rate"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • conversion rate
    ÀüȯÀ²
  • corrected death rate
    Á¤Á¤»ç¸Á·ü
  • cardiac rate
    ½ÉÀå¹Úµ¿¼ö
  • crude birth rate
    º¸ÅëÃâ»ý·ü, Á¶Ãâ»ý·ü
  • crude death rate
    º¸Åë»ç¸Á·ü, Á¶»ç¸Á·ü
  • crude fertility rate
    º¸Åë»ý½Ä·ü, Á¶»ý½Ä·ü
  • crude natural increase rate
    º¸ÅëÀÚ¿¬Áõ°¡À², Á¶ÀÚ¿¬Áõ°¡À²
  • crude survival rate
    º¸Åë»ýÁ¸À², Á¶»ýÁ¸À²
  • cumulative death rate
    ´©Àû»ç¸Á·ü
  • cumulative incidence rate
    ´©Àû¹ß»ý·ü
  • cumulative survival rate
    ´©Àû»ýÁ¸À²
  • cure rate
    Ä¡À¯À²
  • case fatality rate
    Áõ·ÊÄ¡¸í·ü
  • case morbidity rate
    Áõ·ÊÀÌȯÀ²
  • cause-specific rate
    ¿øÀκ°ºñÀ²
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • case fatality rate
    Ä¡¸í·ü
  • case morbidity rate
    Áõ·ÊÀÌȯÀ²
  • cause-specific rate
    ¿øÀκ°Æ¯¼öÀ²
  • cerebral metabolic rate
    ³ú´ë»çÀ²
  • child death rate
    À¯¾Æ»ç¸Á·ü
  • completion rate
    ¿Ï¼º·ü
  • concordance rate
    ÀÏÄ¡À²
  • conversion rate
    ÀüȯÀ²
  • corrected death rate
    Á¤Á¤»ç¸Á·ü
  • corrected life birth rate
    Á¤Á¤Ãâ»ý·ü
  • crude birth rate
    Á¶Ãâ»ý·ü
  • crude death rate
    º¸Åë»ç¸Á·ü, Á¶»ç¸Á·ü
  • crude fertility rate
    Á¶»ý½Ä·ü, Á¶¼öÅÂÀ²
  • crude natural increase rate
    Á¶ÀÚ¿¬Áõ°¡À², º¸ÅëÀÚ¿¬Áõ°¡À²
  • crude survival rate
    Á¶»ýÁ¸À²
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • glomerular pressure =GP
    »ç±¸Ã¼¸ð¼¼°üÇ÷¾Ð(ÞêϹô÷Ù¾á¬Î·úìäâ).
  • glomerular tubular balance
    »ç±¸Ã¼¼¼´¢°ü(¡­á¬Òãί) ±ÕÇü(гû¬).
  • glomerular tubular balance
    »ç±¸Ã¼¼¼´¢°ü ±ÕÇü.
  • primary glomerular insufficiency
    ¿ø¹ß(¼º) »ç±¸Ã¼ºÎÀü(¡­ÞêϹô÷ÝÕîï).
  • primary glomerular insufficiency
    ¿ø¹ß(¼º) »ç±¸Ã¼ºÎÀü(ê«Û¡(àõ) ÞêϹô÷ÝÕîï)
  • BMR=£¾basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • Heart rate
    ½É¹Ú¼ö(ãýÚÑâ¦)
  • MVR=£¾maximus voiding rate
    ÃÖ´ë¹è´¢À².
  • Westergren sedimentation rate
    ¿þ½ºÅͱ׷»Ä§°­¼Óµµ
  • absorbed dose rate
    Èí¼ö¼±·®À²
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü(ËàÌ¡Ë×ËÎËô).
  • adjusted death rate
    Á¶Á¤»ç¸Á·ü.
  • age specific death rate
    ¿¬·Éº° »ç¸Á·ü
  • air kerma-rate constant
    °ø±âÄ¿¸¶À²»ó¼ö
  • alveolar ventilation rate
    ÆóÆ÷ȯ±âºñ(¡­üµÑ¨Ýï)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • glomerular disease
    »ç±¸Ã¼Áúº´
  • glomerular disease
    »ç±¸Ã¼Áúȯ(ÞêϹô÷òðü´)
  • glomerular epithelium
    »ç±¸Ã¼»óÇÇ.
  • glomerular filtrate
    »ç±¸Ã¼¿©°ú¾×.
  • glomerular filtrate
    »ç±¸Ã¼¿©°ú¾×(¡­ÕëΦäû).
  • glomerular kidney
    Å丮ÄáÆÏ
  • glomerular membrane
    »ç±¸Ã¼¸·.
  • glomerular membrane
    »ç±¸Ã¼¸·(¡­Ø¯).
  • glomerular nephritis
    »ç±¸Ã¼¼º ½Å¿°.
  • glomerular porosity
    »ç±¸Ã¼´Ù°øµµ(¡­ÒýÍîöô).
  • glomerular pressure =GP
    »ç±¸Ã¼¸ð¼¼°üÇ÷¾Ð(ÞêϹô÷Ù¾á¬Î·úìäâ).
  • glomerular tubular balance
    »ç±¸Ã¼¼¼´¢°ü ±ÕÇü.
  • glomerular tubular balance
    »ç±¸Ã¼¼¼´¢°ü(¡­á¬Òãί) ±ÕÇü(гû¬).
  • kidney,glomerular disease
    »ç±¸Ã¼ Áúȯ (Þêϳô÷ òðü´)
  • primary glomerular insufficiency
    ¿ø¹ß(¼º) »ç±¸Ã¼ºÎÀü(¡­ÞêϹô÷ÝÕîï).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
SCUF Slow Continous Ultra-Filtration
CF calcaneal fibular [ligament]; calcium leucovorin; calf blood flow; calibration factor; cancer-free; ...
CFC capillary filtration coefficient; colony-forming capacity; cardiofaciocutaneous [syndrome]; chlorofl...
DFPP double filtration plasmapheresis
EFP early follicular phase; effective filtration pressure; endoneural fluid pressure
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
SNFF Single nephron filtration fraction
GFC gel filtration chromatography
GBM Anti-glomerular basement membrane
anti-GBM Anti-glomerular basement membrane
FGS Focal glomerular sclerosis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • peak flow rate
    ÃÖ´ë À¯¼Ó, ÃÖ°í À¯¼Ó
  • prevalance rate
    À¯º´À²
  • prevalence rate
    À¯º´·ü
  • processing rate
    ½Ã¼ú È¿À²
  • rate dependent bundle branch block
    ½É¹Ú ¼ö ÀÇÁ¸¼º °¢ Â÷´Ü
  • rate of ablation
    Á¦°ÅÀ²
  • rate of polymerization
    ÁßÇÕ·ü
  • rate of teeth decayed
    ¿ì½Ä·ü
  • rate-limiting enzyme
    ¼Óµµ Á¶Àý È¿¼Ò
  • repetition rate
    ¹Ýº¹À²
  • respiratory rate
    È£ÈíÀ²
    ¼ºÀÎÀÇ °æ¿ì È£ÈíÀº 1ºÐ¿¡ 16~18ȸ ¾î¸°ÀÌ´Â 24~28ȸ Á¤µµ°¡ Á¤»óÀÌ´Ù.
  • salivary flow rate
    Ÿ¾× ºÐºñÀ²
  • sedimentation rate
    ħ°­À², ħ°­ ¼Óµµ
    µ¿ÀǾî=erythrocyte sedimentation rate.
  • stillbirth rate
    »ç»êÀ²
  • stimulated parotid flow rate
    Àڱؼº ÀÌÇϼ± ºÐºñÀ²
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
rate, respiratory The number of breaths per minute (or, more formally, the number of movements indicative of inspiration and expiration per unit time). In practice, the respiratory rate is usually determined by counting the number of times the chest rises (or falls) per minute. By whatever means, the aim is to determine if the respirations are normal, abnormally fast (tachypnea), abnormally slow (technically termed bradypnea), or nonexistent (apnea).
(12 Dec 1998)
rate schedule A price list showing how the electric bill of a particular type of customer will be calculated by an electric utility company.
(05 Dec 1998)
rate, sed A sedimentation rate, or sed rate , is a blood test that detects and is used to monitor inflammation activity. It is measured by recording the rate at which red blood cells (rbcs) sediment in a tube over time. It increases (the rbcs sediment faster) with more inflammation.
(12 Dec 1998)
rate, sedimentation A sedimentation rate, or sed rate , is a blood test that detects and is used to monitor inflammation activity. It is measured by recording the rate at which red blood cells (rbcs) sediment in a tube over time. It increases (the rbcs sediment faster) with more inflammation.
(12 Dec 1998)
rate setting and review A method of examining and setting levels of payments.
(12 Dec 1998)
general fertility rate A refined measure of fertility in a population; the numerator is the number of live births in a year, the denominator is the number of females of child-bearing age, usually defined as ages 15-44 (but increasingly recognised as extending to age 49).
(05 Mar 2000)
recurrence rate In genetic counseling, the risk that a future offspring will be affected given some specific set of relatives of whom at least one is already affected.
(05 Mar 2000)
case fatality rate The proportion of individuals contracting a disease that die of that disease.
(05 Mar 2000)
maternal death rate The number of maternal deaths that occur as the direct result of the reproductive process per 100,000 live births.
See: rate.
See: maternal death.
(05 Mar 2000)
maternal mortality rate The number of maternal deaths related to childbearing divided by the number of live births (or by the number of live births + foetal deaths) in that year. The maternal mortality rate in the united states in 1993 (and 1994) was 0.1 per 1,000 live births, or 1 mother dying per 10,000 live births.
(12 Dec 1998)
maximal expiratory flow rate <chest medicine, physiology> Measurement of rate of airflow during the first liter expired after the first 200 ml have been exhausted during a forced vital capacity determination. Common abbreviations are MEFR, FEF 202-1200, and fef 0.2-1.2.
Acronym: MEFR
(21 Jun 2000)
maximal midexpiratory flow rate Measurement of rate of airflow over the middle half of a forced vital capacity determination (from the 25 percent level to the 75 percent level). Common abbreviations are mmfr and fef 25%-75%.
(12 Dec 1998)
peak expiratory flow rate Measurement of the maximum rate of airflow attained during a forced vital capacity determination. Common abbreviations are pefr and pfr.
(12 Dec 1998)
peak flow rate Maximum urinary flow rate during voiding as measured by a uroflowmeter.
(05 Mar 2000)
repetition rate The number of pulses per minute, describing an energy outpute.g., ultrasound pulses in echocardiography rather than vascular pulses.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • second rate
    2·ùÀÇ;¿­µîÇÑ;Æò¹üÇÑ
  • third rate
    3µîÀÇ;¿­µîÇÑ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á